Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Taiwan / NCT07568951
Recruiting Observational

Impact of Force Control of Hip Abductor Muscles in Healthy Adults and Individuals With Parkinson's Disease

NCT07568951 · tracked via the Priya Life Science Taiwan tracker
Phase
Observational
Started
2023-08-01
Last updated
2026-05-08

Condition(s) studied

AgingParkinson's Disease (PD)

Investigational drug(s) / intervention(s)

AgeParkinson's disease (PD)

Age: We compare the young, middle-aged, and old groups

Parkinson's disease (PD): We compare the healthy group and PD group.

Study summary

Both aging and Parkinson's disease (PD) negatively affect postural control and increase the risk of falls, with frontal plane balance being particularly challenging for these populations. While previous studies have mainly focused on sagittal plane balance, the contribution of hip abductor muscles remains unclear, especially regarding their force production and control abilities. Therefore, this study aims to investigate hip abductor muscle force production and force control, and to examine whether these factors are associated with postural control, gait, and balance performance in individuals across different ages and those with PD.

Eligibility

Sex
ALL
Min age
20 Years
Max age
85 Years
Healthy volunteers
Accepted
Healthy people Inclusion Criteria: * 20 to 39 years (young), 40 to 59 years (young), and 60-85 years (old) * generally in good health * able to walk 10 m independently * able to follow all instructions Exclusion Criteria: * neurologic, psychiatric, immune, integumentary, and musculoskeletal diseases or disorders which might influence this study * any pain over the lower extremities * uncontrolled cardiovascular diseases * unable to provide informed consent. PD Inclusion Criteria: * clinical diagnosis of idiopathic PD * Hoehn and Yahr stages 1 to 3 * stable anti-PD medications * able to walk 10 m independently * able to follow all instructions Exclusion Criteria: * psychiatric, immune, integumentary, and musculoskeletal diseases or disorders which might influence this study * neurological conditions other than PD * any pain over the lower extremities * uncontrolled cardiovascular diseases * unable to provide informed consent.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Chang Gung Memorial Hospital Taoyuan Taiwan Recruiting
Chang Gung University Taoyuan Taiwan Recruiting

More Chang Gung Memorial Hospital trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07568951 on ClinicalTrials.gov ↗ ← All trials in Taiwan